KALV NASDAQ
KalVista Pharmaceuticals, Inc.
1W: +0.2%
1M: +0.8%
3M: +59.4%
YTD: +74.6%
1Y: +100.6%
3Y: +173.3%
5Y: -3.9%
$27.00
Last traded 2026-06-12 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$102M
Revenue
+0.0% YoY
$-141M
Net Income
+19.7% YoY
$-64M
Free Cash Flow
+50.1% YoY
93.4%
Gross Margin
-19.2%
Op. Margin
-9.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-198.3%
ROA-46.2%
ROIC628.8%
Valuation
P/E-8.4
P/B-503.3
EV/EBITDA-8.0
Leverage
Debt/Equity-104.83
Current Ratio5.58
Interest Cov.-6.1x
Quality Scores
Piotroski F4/9
Altman Z-1.38
Beneish M0.00